Screening EGFR Mutations in NSCLC by Immunohistochemistry

被引：0
作者：
Gaber, Rania [1 ]
Watermann, Iris [2 ]
Vollmer, Ekkehard [2 ]
Goldmann, Torsten [2 ]
机构：
[1] Univ Alexandria, Fac Med, Pathol, Alexandria, Egypt
[2] Res Ctr Borstel, Clin & Expt Pathol, Borstel, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
EGFR mutations; DNA sequencing; NSCLC; Immunohistochemistry;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-015
引用
收藏
页码：S582 / S583
页数：2
相关论文
共 50 条
  • [41] Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
    Ou, Sai-Hong Ignatius
    Le, Xiuning
    Nagasaka, Misako
    Reungwetwattana, Thanyanan
    Ahn, Myung-Ju
    Lim, Darren W. T.
    Santos, Edgardo S.
    Shum, Elaine
    Lau, Sally C. M.
    Lee, Jii Bum
    Calles, Antonio
    Wu, Fengying
    Lopes, Gilberto
    Sriuranpong, Virote
    Tanioki, Junko
    Horinouchi, Hidehito
    Garassino, Marina C.
    Popat, Sanjay
    Besse, Benjamin
    Rosell, Rafael
    Soo, Ross A.
    LUNG CANCER-TARGETS AND THERAPY, 2024, 15 : 87 - 114
  • [42] Spectrum of Cancer Types in Kindreds with NSCLC and EGFR T790M Mutations: Results from INHERIT EGFR
    Wiesner, Georgia
    Ashworth, Renee
    Heng, Jennifer C.
    Rainville, Irene
    Mcreynolds, Katharine
    Sable-Hunt, Alicia
    Garber, Judy
    Carbone, David P.
    Oxnard, Geoffrey R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S216 - S216
  • [43] Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
    Zhang, Shannon S.
    Zhu, Viola W.
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 61 - 65
  • [44] Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO)
    Pizzutilo, E. G.
    Agostara, A. G.
    Oresti, S.
    Signorelli, D.
    Giannetta, L. G.
    Stabile, S.
    Lauricella, C.
    Amatu, A.
    Brambilla, M.
    Lo Russo, G.
    Proto, C.
    Mazzeo, L.
    Beninato, T.
    Siringo, M.
    Giusti, R.
    Filetti, M.
    Genova, C.
    Barletta, G.
    Russano, M.
    Di Fazio, G. R.
    Tosoni, E.
    Metro, G.
    Pilotto, S.
    Carta, A.
    Mazzoni, F.
    Roca, E.
    Gelibter, A. J.
    Gori, S.
    Berardi, R.
    Cerea, G.
    Sartore-Bianchi, A.
    Siena, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S418 - S419
  • [45] Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment
    J L Kuiper
    S M S Hashemi
    E Thunnissen
    P J F Snijders
    K Grünberg
    E Bloemena
    D Sie
    P E Postmus
    D A M Heideman
    E F Smit
    British Journal of Cancer, 2016, 115 : 1504 - 1512
  • [46] Molecular Characteristics of BRAF Mutations in EGFR Mutant NSCLC after Progression on EGFR TKIs and Response to Combination Targeted Therapy
    Fang, W.
    Hu, J.
    Huang, Y.
    Xu, C.
    Wang, W.
    Yao, G.
    Shao, Y. W.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S628 - S629
  • [47] Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment
    Kuiper, J. L.
    Hashemi, S. M. S.
    Thunnissen, E.
    Snijders, P. J. F.
    Grunberg, K.
    Bloemena, E.
    Sie, D.
    Postmus, P. E.
    Heideman, D. A. M.
    Smit, E. F.
    BRITISH JOURNAL OF CANCER, 2016, 115 (12) : 1504 - 1512
  • [48] Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision
    Sousa, A. C.
    Silveira, C.
    Janeiro, A.
    Malveiro, S.
    Oliveira, A. R.
    Felizardo, M.
    Nogueira, F.
    Teixeira, E.
    Martins, J.
    Carmo-Fonseca, M.
    LUNG CANCER, 2020, 139 : 35 - 40
  • [49] Prognostic significance of EGFR and KRAS mutations in NSCLC patients with brain metastases treated with radiosurgery
    Parikh, Neil R.
    Likhacheva, Anna
    Pinnix, Chelsea
    Allen, Pamela K.
    Prabhu, Sujit S.
    Guha-Thakurta, Nandita
    Welsh, James W.
    Brown, Paul D.
    Chang, Eric L.
    JOURNAL OF RADIOSURGERY AND SBRT, 2015, 3 (03): : 171 - 178
  • [50] First-line treatment in NSCLC harboring EGFR common mutations: EGFR TKI in monotherapy or in combination with anti-VEGF?
    Passaro, Antonio
    Spitaleri, Gianluca
    de Marinis, Filippo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (08) : 799 - 801
12345